BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15068821)

  • 1. Legal requirements for "functional food" claims.
    Patrick Noonan W; Noonan C
    Toxicol Lett; 2004 Apr; 150(1):19-24. PubMed ID: 15068821
    [No Abstract]   [Full Text] [Related]  

  • 2. From herbal Prozac to Mark McGwire's tonic: how the Dietary Supplement Health and Education Act changed the regulatory landscape for health products.
    Kaczka KA
    J Contemp Health Law Policy; 2000; 16(2):463-99. PubMed ID: 10970182
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
    Villafranco JE; Lustigman AB
    Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227
    [No Abstract]   [Full Text] [Related]  

  • 4. Dietary supplements and lessons to be learned from GRAS.
    Burdock GA
    Regul Toxicol Pharmacol; 2000 Feb; 31(1):68-76. PubMed ID: 10715226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. So you want to market a food and to make health-related claims--how far can you go? What rules of law will govern the claims you want to make?
    McNamara SH
    Food Drug Law J; 1998; 53(3):421-36. PubMed ID: 10346720
    [No Abstract]   [Full Text] [Related]  

  • 6. Public health. Toward evidence-based health claims for foods.
    Katan MB; de Roos NM
    Science; 2003 Jan; 299(5604):206-7. PubMed ID: 12522235
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical pharmacology and dietary supplements: an evolving relationship.
    Gurley BJ
    Clin Pharmacol Ther; 2010 Feb; 87(2):235-8. PubMed ID: 19940848
    [No Abstract]   [Full Text] [Related]  

  • 8. Health-benefit claims for probiotic products.
    Heimbach JT
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S122-4; discussion S144-51. PubMed ID: 18181716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inappropriate advertising of dietary supplements.
    Applequist WL
    N Engl J Med; 2003 May; 348(22):2255-6; author reply 2255-6. PubMed ID: 12774809
    [No Abstract]   [Full Text] [Related]  

  • 10. Maintaining a level playing field: the need for a uniform standard to evaluate health claims for foods and dietary supplements.
    Pappas CD
    Food Drug Law J; 2002; 57(1):25-41. PubMed ID: 12118479
    [No Abstract]   [Full Text] [Related]  

  • 11. Inappropriate advertising of dietary supplements.
    de Lemos ML
    N Engl J Med; 2003 May; 348(22):2255-6; author reply 2255-6. PubMed ID: 12774807
    [No Abstract]   [Full Text] [Related]  

  • 12. US Food and Drug Administration regulations governing label claims for food products, including probiotics.
    Saldanha LG
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S119-21; discussion S144-51. PubMed ID: 18181715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report of the FDLI Futurist Task Force on Dietary Supplements.
    McNamara SH
    Food Drug Law J; 2000; 55(1):17-20. PubMed ID: 12269357
    [No Abstract]   [Full Text] [Related]  

  • 14. Ambiguities of the Dietary Supplement Health and Education Act of 1994.
    Pinco RG; Rubin PD
    Food Drug Law J; 1996; 51(3):383-405. PubMed ID: 11797716
    [No Abstract]   [Full Text] [Related]  

  • 15. How physicians should evaluate dietary supplements.
    Glisson JK; Walker LA
    Am J Med; 2010 Jul; 123(7):577-82. PubMed ID: 20493463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulating dietary supplement safety under the dietary supplement health and education act: brave new world or pyrrhic victory?
    Silverglade BA
    Food Drug Law J; 1996; 51(2):319-21. PubMed ID: 11822324
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulatory initiatives for dietary supplements.
    FDA Consum; 2005; 39(1):27. PubMed ID: 15803593
    [No Abstract]   [Full Text] [Related]  

  • 18. Inappropriate advertising of dietary supplements.
    Taylor H
    N Engl J Med; 2003 May; 348(22):2255-6; author reply 2255-6. PubMed ID: 12773657
    [No Abstract]   [Full Text] [Related]  

  • 19. [Labelling, claims and infant or young child special foods].
    Ghisolfi J
    Arch Pediatr; 2006 Jun; 13(6):560-1. PubMed ID: 16698251
    [No Abstract]   [Full Text] [Related]  

  • 20. Disclaimers in dietary supplement print advertising: the bodybuilding category as a model case for change.
    Soller RW; Rice LG; Ambrose PJ
    Food Drug Law J; 2007; 62(2):375-86. PubMed ID: 17632967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.